Table 3.
Application of aptamers in clinical trials
Aptamers | Targets | Phase | References |
---|---|---|---|
Macugen | VEGF | Approved | 168 |
E10030 | PDGF | Phase III | 169 |
AS1411 | Nucleolin | Phase II | 124 |
ARC1779 | vWF | Phase II | 170 |
NU172 | Thrombin | Phase II | 171 |
NOX-A12 | SDF-1 | Phase II | 172 |
NOX-E36 | MCP-1 | Phase II | 172 |
NOX-H94 | Hepcidin | Phase I | 173 |
ARC1905 | Complement component 5 (C5) | Phase II | 174 |
REG1 | Coagulation factor IXa | Phase III | 175 |
ARC19499 | Hemophilia | Phase I | 176 |